(Q42906411)

English

Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection

scientific article published on 15 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 November 2017

Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection (English)

1 reference

Europe PubMed Central

10 November 2017

1 reference

based on heuristic

inferred from title

author name string

Nicoletta Eliopoulos

1

1 reference

Europe PubMed Central

10 November 2017

Jing Zhao

2

1 reference

Europe PubMed Central

10 November 2017

Manaf Bouchentouf

3

1 reference

Europe PubMed Central

10 November 2017

Kathy Forner

4

1 reference

Europe PubMed Central

10 November 2017

Elena Birman

5

1 reference

Europe PubMed Central

10 November 2017

Shala Yuan

6

1 reference

Europe PubMed Central

10 November 2017

Marie-Noelle Boivin

7

1 reference

Europe PubMed Central

10 November 2017

Daniel Martineau

8

1 reference

Europe PubMed Central

10 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 September 2010

1 reference

Europe PubMed Central

10 November 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

10 November 2017

299

1 reference

Europe PubMed Central

10 November 2017

6

1 reference

Europe PubMed Central

10 November 2017

F1288-98

1 reference

Europe PubMed Central

10 November 2017

Stromal cells protect against acute tubular injury via an endocrine effect.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Therapeutic applications of mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Contribution of stem cells to kidney repair.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Surgically relevant aspects of stem cell paracrine effects

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Ischemic and non-ischemic acute kidney injury cause hepatic damage

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Advances in cell therapy for renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Cell therapy for disorders of bone.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Bone marrow stem cells contribute to repair of the ischemically injured renal tubule

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Acute renal failure: much more than a kidney disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Maladaptive role of IL-6 in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Exogenous nitric oxide downregulates MIP-2 and MIP-1alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

The regenerative potential of stem cells in acute renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Bone marrow stromal cells for repair of the spinal cord: towards clinical application

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Cardiac cell-based therapy: cell types and mechanisms of actions

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Stem-cell approaches for kidney repair: choosing the right cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Stem cell transplantation: the lung barrier.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Plasma cytokine levels predict mortality in patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

The activation of Akt/PKB signaling pathway and cell survival.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Hepatocyte growth factor in renal failure: promise and reality

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00671.2009

21 January 2018

Identifiers

10.1152/AJPRENAL.00671.2009

1 reference

Europe PubMed Central

10 November 2017

1 reference

Europe PubMed Central

10 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42906411&oldid=1973479860"